CAS 937370-10-0

Pemetrexed Disodium Enantiomer ((2R)-2-[[4-[2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid, sodium salt)

CAS : 937370-10-0

Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoi

Formule : C₂₀H₁₉N₅O₆Na

Couleur et forme : Pale Green Solid

Masse moléculaire : 576.5

Ref: 45-1A00620

Pemetrexed EP Impurity E Disodium Salt (Pemetrexed Enantiomer Disodium Salt)

CAS : 937370-10-0

Formule : C₂₀H₁₉N₅O₆·2Na

Couleur et forme : Off-White Solid

Masse moléculaire : 425.40 2*22.99

Ref: 4Z-P-688

(2R)-2-[[4-[2-(2-Amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic Acid Disodium Salt ((R)-Pemetrexed Disodium)

CAS : 937370-10-0

Couleur et forme : Neat

Ref: 86-MM1301.10

D-Pemetrexed Disodium

Produit contrôlé

CAS : 937370-10-0

Formule : C₂₀H₁₉N₅O₆·2Na

Couleur et forme : Neat

Masse moléculaire : 471.3743

Ref: TR-P945950

D-Pemetrexed Hydrate

CAS : 937370-10-0

Pemetrexed is an antifolate drug that is used to treat cancer. It is a prodrug of pemetrexed disodium, which is converted to pemetrexed in the body by esterases. Pemetrexed is metabolized to its active form, D-pemetrexed, which inhibits DNA synthesis and the growth of cells by inhibiting thymidylate synthase. D-Pemetrexed hydrate is a high purity, pharmacopoeia grade impurity standard for use in research and development or as a custom synthesis. It has been shown to inhibit the growth of certain types of cancer cells and can be used in combination with other treatments such as chemotherapy or radiation therapy.

Formule : C₂₀H₂₃N₅O₇

Degré de pureté : Min. 95%

Masse moléculaire : 445.43 g/mol

Ref: 3D-MMB37010